help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chronwall, B. M.
Right arrow Articles by O'Donohue, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chronwall, B. M.
Right arrow Articles by O'Donohue, T. L.

Endocrinology, Vol 120, 1201-1211, Copyright © 1987 by Endocrine Society


ARTICLES

Histological evaluation of the dopaminergic regulation of proopiomelanocortin gene expression in the intermediate lobe of the rat pituitary, involving in situ hybridization and [3H]thymidine uptake measurement

BM Chronwall, WR Millington, WS Griffin, JR Unnerstall and TL O'Donohue

The melanotroph, a polyhedral secretory cell with an ovoid smooth nucleus, is the primary cell type of the intermediate lobe (IL) of the rat pituitary. The melanotrophs are not uniform, but differ in the tinctorial properties of their cytoplasm; some cells appear distinctly darker, others lighter, and cells staining in intermediate shades are also found. In addition, in situ hybridization using proopiomelanocortin (POMC) probes shows an uneven distribution of POMC mRNA among melanotrophs, indicating that different cells maintain different levels of biosynthetic activity. Dopaminergic drugs known to alter the secretion of POMC-related peptides from the IL produced parallel changes in histological staining properties and the amount of POMC mRNA per cell, as determined by in situ hybridization. Acute bromocriptine treatment (6 h) produced a dramatic reduction in grain counts over melanotroph cytoplasm (to 10% of the control levels). A similar reduction persisted after chronic treatment. Six hours after a single haloperidol injection, the grain counts were 180% of control levels. After chronic haloperidol treatment, they were further elevated to 300% of control levels. Chronic bromocriptine and haloperidol treatment also changed the thickness of the IL. Bromocriptine reduced and haloperidol treatment increased the number of cell layers in the IL by changing the rate of cell proliferation. Thus, haloperidol treatment significantly increased and bromocriptine treatment significantly decreased the number of melanotrophs labeled by [3H]thymidine. The mitotic index followed the same trend. These results suggest that dopamine regulation of the IL acts by two different mechanisms: POMC gene expression and cellular proliferation. The change in POMC gene expression is the cell's first rapid response. The influence on the cell cycle appears after subchronic and chronic treatment.


This article has been cited by other articles:


Home page
J EndocrinolHome page
S.-N. Lee, B. Peng, R. Desjardins, J. E Pintar, R. Day, and I. Lindberg
Strain-specific steroidal control of pituitary function
J. Endocrinol., March 1, 2007; 192(3): 515 - 525.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Vazquez-Martinez, J. P. Castano, M. C. Tonon, H. Vaudry, F. Gracia-Navarro, and M. M. Malagon
Melanotrope secretory cycle is regulated by physiological inputs via the hypothalamus
Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E1039 - E1046.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. Ben-Jonathan and R. Hnasko
Dopamine as a Prolactin (PRL) Inhibitor
Endocr. Rev., December 1, 2001; 22(6): 724 - 763.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. L. González de Aguilar, M. M. Malagón, R. M. Vázquez-Martínez, A. J. Martínez-Fuentes, M. C. Tonon, H. Vaudry, and F. Gracia-Navarro
Differential Effects of Dopamine on Two Frog Melanotrope Cell Subpopulations
Endocrinology, January 1, 1999; 140(1): 159 - 164.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
R. Hnasko, S. Khurana, N. Shackleford, R. Steinmetz, M. J. Low, and N. Ben-Jonathan
Two Distinct Pituitary Cell Lines from Mouse Intermediate Lobe Tumors: A Cell that Produces Prolactin-Regulating Factor and a Melanotroph
Endocrinology, December 1, 1997; 138(12): 5589 - 5596.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. L. Gonzalez de Aguilar, M. M. Malagon, R. M. Vazquez-Martinez, I. Lihrmann, M.-C. Tonon, H. Vaudry, and F. Gracia-Navarro
Two Frog Melanotrope Cell Subpopulations Exhibiting Distinct Biochemical and Physiological Patterns in Basal Conditions and under Thyrotropin-Releasing Hormone Stimulation
Endocrinology, March 1, 1997; 138(3): 970 - 977.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
Nikitin AYu and W H Lee
Early loss of the retinoblastoma gene is associated with impaired growth inhibitory innervation during melanotroph carcinogenesis in Rb+/- mice.
Genes & Dev., August 1, 1996; 10(15): 1870 - 1879.
[Abstract] [PDF]


Home page
ScienceHome page
L. Tecott, J. Barchas, and J. Eberwine
In situ transcription: specific synthesis of complementary DNA in fixed tissue sections
Science, June 17, 1988; 240(4859): 1661 - 1664.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1987 by The Endocrine Society